Hearing News Watch

Featured image for “Rural vs Urban: The Growing Divide in Hearing Care Access for Older Adults”
Oct. 04, 2024

Rural vs Urban: The Growing Divide in Hearing Care Access for Older Adults

HHTM
Hearing loss among older adults in the United States has become a major public health concern in recent years. Untreated hearing loss is associated with serious issues like depression, social isolation, and cognitive decline. However, despite the availability of hearing aids, fewer than 20% of adults with hearing loss choose to use them. A new study led by Dr. Sarah
Featured image for “Amplifon Named One of America’s 200 Most Loved Workplaces by Newsweek”
Oct. 02, 2024

Amplifon Named One of America’s 200 Most Loved Workplaces by Newsweek

HHTM
MINNEAPOLIS, MINNESOTA – Amplifon, the parent company of Miracle-Ear and a global leader in hearing care services and solutions, has been recognized in Newsweek’s annual ranking of America’s 200 Most Loved Workplaces®. Amplifon is the only company in the hearing care industry to be included in this prestigious list. The ranking, developed by Newsweek in collaboration with Most Loved Workplaces®
Featured image for “Justice Department Reaches Agreement with Wisconsin Prisons to Improve Access for Deaf and Hard of Hearing Inmates”
Oct. 01, 2024

Justice Department Reaches Agreement with Wisconsin Prisons to Improve Access for Deaf and Hard of Hearing Inmates

HHTM
The U.S. Department of Justice (DOJ) has reached a landmark settlement with the Wisconsin Department of Corrections (DOC) to ensure that prisoners with hearing disabilities receive the necessary accommodations while incarcerated. The agreement follows a DOJ investigation under the Americans with Disabilities Act (ADA), which revealed that the Wisconsin DOC had been failing to provide adequate support for inmates with
Featured image for “Spiral Therapeutics Reports Encouraging Phase 1b/2a Trial Results for SPT-2101 in Meniere’s Disease”
Sep. 30, 2024

Spiral Therapeutics Reports Encouraging Phase 1b/2a Trial Results for SPT-2101 in Meniere’s Disease

HHTM
SOUTH SAN FRANCISCO, CALIFORNIA — Spiral Therapeutics, Inc., a clinical-stage company focused on developing novel therapies for inner ear disorders, announced the successful completion of the Phase 1b/2a clinical trial of SPT-2101 (6% dexamethasone) in Meniere’s disease. Data review of 21 patients showed a significant reduction in vertigo frequency and severity. The study recruited 21 patients across sites in Perth,
Featured image for “Mason Branstrator Provides Hearing Health Inspiration, Education, and Resources to a Growing Online Community”
Sep. 30, 2024

Mason Branstrator Provides Hearing Health Inspiration, Education, and Resources to a Growing Online Community

HHTM
Mason Branstrator, a social media influencer and advocate for people with disabilities, continues to provide education and resources on hearing health and adaptive living to his growing online community. After a skiing accident left him paralyzed from the waist down, Branstrator could have retreated from his ambitions. However, his drive to overcome both physical challenges and childhood hearing loss has
Featured image for “IHS 2024 Event Highlights: Networking, Education, and Industry Insights Take Center Stage”
Sep. 26, 2024

IHS 2024 Event Highlights: Networking, Education, and Industry Insights Take Center Stage

HHTM
FARMINGTON HILLS, MICHIGAN – Attendees of the International Hearing Society (IHS) 2024 Conference & Expo, held in Louisville, Kentucky, embraced the conference theme of “Take the Lead” in record numbers, with attendance increasing by 20% and sponsor engagement rising by 25% compared to last year. The Kentucky Derby-themed event provided participants the opportunity to earn up to 14.5 continuing education
Featured image for “EUHA Announces New Executive Committee and Council of Honour Members”
Sep. 26, 2024

EUHA Announces New Executive Committee and Council of Honour Members

HHTM
The EUHA held its General Meeting on 25 September 2024, during which members of the EUHA Executive Committee, Auditing Committee, and Council of Honour were elected. The new leadership is now ready to move forward with their term. Beate Gromke was re-elected as President, marking her third term. Eva Keil-Becker will continue as Vice President, and Peter Möckel remains both
Featured image for “EUHA2024: EUHA-Live Area Set to Showcase Industry Innovations”
Sep. 23, 2024

EUHA2024: EUHA-Live Area Set to Showcase Industry Innovations

HHTM
The European Union of Hearing Aid Acousticians (EUHA) and the German Hearing Instruments Industry Association (BVHI) continue to advance the International Congress of Hearing Aid Acousticians. A newly introduced feature, the EUHA-Live Area, will include a stage and a designated meeting and networking space, enhancing the connection between the Congress and the Industry Exhibition through spatial arrangement and events. Within
Featured image for “Sensorion Announces New Positive Clinical Data Across Its Gene Therapy and Small Molecule Programs at WCA Conference”
Sep. 20, 2024

Sensorion Announces New Positive Clinical Data Across Its Gene Therapy and Small Molecule Programs at WCA Conference

HHTM
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat, and prevent hearing loss disorders, announced new positive medical data from its clinical programs, SENS-501 and SENS-401, during a symposium at the 36th World Congress of Audiology (WCA) in Paris, held at CNIT, La Défense, France. The company presented data from
Featured image for “Lineage Presents Promising Preclinical Results for Auditory Neuronal Cell Therapy”
Sep. 19, 2024

Lineage Presents Promising Preclinical Results for Auditory Neuronal Cell Therapy

HHTM
CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that preclinical results with ReSonance (ANP1), the company’s auditory neuronal cell transplant for the treatment of hearing loss, were presented at the 59th Annual Inner Ear Biology Workshop by Ofer Wiser, Ph.D. Senior Scientist, Technological Innovation